Jupiter Neurosciences (JUNS) Other Working Capital Changes (2024 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Other Working Capital Changes of -$35352.0 for Q4 2025, down 125.46% year-over-year from $138826.0 in Q4 2024, and down 9.37% quarter-over-quarter from -$32324.0 in Q3 2025.
Jupiter Neurosciences (JUNS) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Other Working Capital Changes for 2 consecutive years, with -$35352.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 125.46% year-over-year to -$35352.0; the TTM figure through Dec 2025 stood at -$7544.0 (changed N/A YoY), while the FY2025 annual figure was -$7544.0, down 106.63% from the prior year.
- Other Working Capital Changes declined to -$35352.0 in Q4 2025 per JUNS's latest filing, from -$32324.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $138826.0 in Q4 2024 and bottomed at -$35352.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,352.00 |
| Dec 31, 2025 | -35,352.00 |
| Dec 31, 2025 | -35,352.00 |
| Sep 30, 2025 | -32,324.00 |
| Sep 30, 2025 | -32,324.00 |
| Sep 30, 2025 | -32,324.00 |
| Jun 30, 2025 | 36,026.00 |
| Jun 30, 2025 | 36,026.00 |
| Jun 30, 2025 | 36,026.00 |
| Mar 31, 2025 | 24,106.00 |
| Mar 31, 2025 | 24,106.00 |
| Mar 31, 2025 | 24,106.00 |
| Dec 31, 2024 | 138,826.00 |
| Dec 31, 2024 | 138,826.00 |
| Dec 31, 2024 | 138,826.00 |